Latest Reports
News Functions
Additional Functions
11 July 2024
Heidelberg Pharma AG
Half-yearly financial report 2023/2024
29 April 2024
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2023/2024
25 April 2024
Heidelberg Pharma AG
Q1 Mitteilung / Q1 Finanzbericht 2023/2024
26 March 2024
Heidelberg Pharma AG
Annual financial report 2022/2023
Heidelberg Pharma AG
Jahresfinanzbericht 2022/2023
12 October 2023
Heidelberg Pharma AG
Q3 statement / Q3 financial report 2022/2023
13 July 2023
Heidelberg Pharma AG
Half-yearly financial report 2022/2023
19 April 2023
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2022/2023
28 March 2023
Heidelberg Pharma AG
Annual financial report 2021/2022
24 March 2023
Heidelberg Pharma AG
Jahresfinanzbericht 2021/2022
13 October 2022
Heidelberg Pharma AG
Q3 statement / Q3 financial report 2021/2022
12 July 2022
Heidelberg Pharma AG
Half-yearly financial report 2021/2022
28 April 2022
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2021/2022
31 March 2022
Heidelberg Pharma AG
Jahresfinanzbericht 2020/2021
29 March 2022
Heidelberg Pharma AG
Annual financial report 2020/2021
11 October 2021
Heidelberg Pharma AG
Q3 statement / Q3 financial report 2020/2021
19 July 2021
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2020/2021
Heidelberg Pharma AG
Half-yearly financial report 2020/2021
Heidelberg Pharma AG
Annual financial report 2019/2020
Latest News
News Functions
Additional Functions
11 July 2024
Heidelberg Pharma AG
Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
21 June 2024
Heidelberg Pharma AG
Heidelberg Pharma reports on the results of the Annual General Meeting 2024
18 June 2024
Heidelberg Pharma AG
Heidelberg Pharma AG announces updated guidance
23 May 2024
Heidelberg Pharma AG
Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
13 May 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 20.06.2024 in Ladenburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
25 April 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024